keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
DAY TWO - PST/PDT (Pacific Daylight, GMT-7)
keyboard_arrow_leftSearch & Filter
search
Streams
Formats
DAY TWO - PST/PDT (Pacific Daylight, GMT-7)
search
Streams
Formats
10:00am - 10:05am5 mins
Opening Remarks - Live
10:05am - 10:25am20 mins
Plenary Session
Keynote Address - Live - Innovate to Transform - From Good to Great Biomanufacturing
- Thomas Seewoester, Ph.D. - Vice President, External Operations, Amgen, Inc.
10:30am - 11:00am30 mins
Plenary Session
Panel Discussion - Live - “ Looking to the Future” – Exploring areas in Biopharma where Innovation will Change Our Industry
11:05am - 11:25am20 mins
Track 1: Cell Line Development & Engineering
Mitigation of Antibody Sulfation by CHO Host Selection and Inhibitor Supplementation
- Ren Liu - Associate Principal Scientist, Merck
11:05am - 11:25am20 mins
Track 2: Cell Culture
Raw Material Risk Mitigation & Control Strategies to Reduce Raw Material Variability
- Thomas Matthews - Scientist II, Biogen
11:05am - 11:25am20 mins
Track 3: Recovery & Purification
Evolution of Antibodies and the Related Downstream Challenges
- Sanchayita Ghose, PhD - Executive Director, Global Downstream Bioprocess Development, Biologics Development, BMS
11:05am - 11:25am20 mins
Track 4: Manufacturing Strategy & Bioprocessing 4.0
Opportunities to Leverage Digital and Smart Technologies in Bioprocessing
- Samet Yildirim - Manager, Technology & Innovation, Global Technology Management, Boehringer Ingelheim Fremont, Inc.
11:05am - 11:25am20 mins
Track 5: Intensified & Continuous Processing
Talk Title TBD
- Tom Ransohoff - Co-Founder and COO, 4th Dimension Bioprocess, Inc.
11:05am - 11:25am20 mins
Track 6: Cell & Gene Therapies
Novel Filtration Systems & Cell Processing in Automated Closed Systems for Autologous Therapies
- Manuel Carrondo - Vice-President, Prof. of Chemical & Biochemical Engineering, FCT-UNL (Jubilado), iBET
11:05am - 11:15am10 mins
Live Labs
Single-Step Column Purification for H1N1 Virus Using Nuvia HP-Q AEX Chromatography
- Sharon Bola - Global Product Manager, Bio-Rad Laboratories
11:15am - 11:25am10 mins
Live Labs
Presentation from Meissner Filtration
11:25am - 11:35am10 mins
Live Labs
Improving Tech Transfer from Research to Development
- Kate Quigley - Product Marketing Lead, Benchling
11:30am - 11:50am20 mins
Track 1: Cell Line Development & Engineering
Accelerating the Delivery of Purified Antibodies in Early Discovery Through the Utilization of a Novel High Throughput, One-Step Transient to Stable Cell Line Generation Process
- Marina Alvi - Senior Research Scientist, Lilly Biotechnology Center-San Diego, Eli Lilly
11:30am - 11:50am20 mins
Track 2: Cell Culture
Asparagine Metabolism and its Importance for the Development of Feeds for High Producing Cell Lines During Fed-Batch Bioreactor Production
- Sandra Bennun Serrano - Staff Engineer, Regeneron
11:30am - 11:50am20 mins
Track 3: Recovery & Purification
The Challenges of Harvest and Downstream Processing for Bispecific Antibodies during the Recovery & Purification
- Ji Zheng - Director, Downstream Process Development, Biologics Development & Manufacturing, BMS
11:30am - 11:50am20 mins
Track 4: Manufacturing Strategy & Bioprocessing 4.0
Digital Transformation: How to make the cultural shift
- Rick St. John, Ph.D. - Head of Digital Sciences, Genentech, Inc
11:30am - 11:50am20 mins
Track 5: Intensified & Continuous Processing
Standards, Best Practices and Guidance for Continuous Bioprocessing
- Kurt Brorson, PhD - Vice President, Technical, Parexel International
11:30am - 11:50am20 mins
Track 6: Cell & Gene Therapies
High Reliability and High Confidence Genome Scale Engineering of T-Cells
- Tanya Warnecke - CTO, Artisan Bio
11:35am - 11:45am10 mins
Live Labs
The NEW OsmoTECH XT Single Sample Osmometer: In a class of its own, solving some of your toughest QC testing challenges
- Shweta Nair - Sr. Product Manager, Biotechnology, Advanced Instruments, LLC
11:45am - 11:55am10 mins
Live Labs
Two-Step Purification of Novel Mouse Monoclonal Antibody from Hybridoma Cell Line
- Jukka Kervinen PhD - Scientist, Applications Group Manager, TOSOH BIOSCIENCE LLC
11:55am - 12:15pm20 mins
Track 1: Cell Line Development & Engineering
A New Data-Driven Workflow for Cell Line Development
- Duncan Borthwick - Global Marketing Manager, Solentim
11:55am - 12:15pm20 mins
Track 2: Cell Culture
High Throughput Upstream Processing and Quality Analysis via Microfluidic Capillary Electrophoresis
- James Geiger, PhD - Field Application Scientist, PerkinElmer
11:55am - 12:15pm20 mins
Track 3: Recovery & Purification
Harnessing IMAC to Enable an Immobilized Enzyme Cascade for the Synthesis of Islatravir
- Jacob H. Forstater, PhD - Associate Principal Scientist, Merck Process Research & Development, Merck Research Laboratories
11:55am - 12:15pm20 mins
Track 4: Manufacturing Strategy & Bioprocessing 4.0
The Evolution of AI - Accessibility for Everyone. How Will Artificial Intelligence Help Biotech Scientists?
- Hemant Garg - Product Manager Analytics, MilliporeSigma
- Philippe Eberhard - IT Architect, MilliporeSigma
11:55am - 12:15pm20 mins
Track 5: Intensified & Continuous Processing
Scientific Track Presentation - Live with Q&A
11:55am - 12:15pm20 mins
Track 6: Cell & Gene Therapies
On The Importance Of Monitoring Both Transfection And Transduction Efficiencies In Cell Therapy Development
- Derek C. Lenz - Senior Marketing Manager, Biopharma, Beckman Coulter Life Sciences
12:20pm - 12:40pm20 mins
Track 1: Cell Line Development & Engineering
Sponsored Luncheon Presentations
12:20pm - 12:40pm20 mins
Track 2: Cell Culture
Sponsored Luncheon Presentations
12:20pm - 12:40pm20 mins
Track 3: Recovery & Purification
Sponsored Luncheon Presentations
12:20pm - 12:40pm20 mins
Track 4: Manufacturing Strategy & Bioprocessing 4.0
Sponsored Luncheon Presentations
12:20pm - 12:40pm20 mins
Track 5: Intensified & Continuous Processing
Sponsored Luncheon Presentations
12:20pm - 12:40pm20 mins
Track 6: Cell & Gene Therapies
Sponsored Luncheon Presentations
12:45pm - 1:10pm25 mins
Track 1: Cell Line Development & Engineering
Roundtable Discussions
12:45pm - 1:10pm25 mins
Track 2: Cell Culture
Roundtable Discussions
12:45pm - 1:10pm25 mins
Track 3: Recovery & Purification
Roundtable Discussions
12:45pm - 1:10pm25 mins
Track 4: Manufacturing Strategy & Bioprocessing 4.0
Roundtable Discussions
12:45pm - 1:10pm25 mins
Track 5: Intensified & Continuous Processing
Roundtable Discussions
12:45pm - 1:10pm25 mins
Track 6: Cell & Gene Therapies
Roundtable Discussions
1:15pm - 1:35pm20 mins
Track 1: Cell Line Development & Engineering
KEYNOTE: Reimagining Yeast for Monoclonal Antibody Production
- Chris Love - Professor of Chemical Engineering, MIT
1:15pm - 1:35pm20 mins
Track 2: Cell Culture
Utilizing Multi-Omics to Drive Upstream Process Changes to Mitigate Problematic HCPs
- Taylor Forte - Engineer, Biogen
1:15pm - 1:35pm20 mins
Track 3: Recovery & Purification
Innovative buffer platform for downstream process intensification
- Victor Pasquier - DSP Technology Innovation Specialist, Merck
1:15pm - 1:35pm20 mins
Track 4: Manufacturing Strategy & Bioprocessing 4.0
The role of Hybrid modeling in bioprocess digitalization – Moving from a data-centric to a knowledge-centric approach
- Moritz von Stosch - Chief Innovation Officer, DataHow AG.
1:15pm - 1:35pm20 mins
Track 5: Intensified & Continuous Processing
Transition from Fed Batch to Intensified Fed Batch – Impact on COG, Core Technology, Facility Fit, and the Patient
- Jeong Lee, Ph.D. - Principal Scientist, Cell Culture and Fermentation Sciences, AstraZeneca
1:15pm - 1:35pm20 mins
Track 6: Cell & Gene Therapies
Platform Development in AAV Manufacturing: Cost and Timeline impact on clinical development
- Andy Holt - Executive Vice President, Commercial Development - Manufacturing, Asklepios BioPharmaceutical, Inc. (AskBio), USA
1:15pm - 2:30pm75 mins
Live Labs
5-10 minute live demos and presentations focusing on the most innovative technologies, equipment and services to hit today's biopharmaceutical market
1:40pm - 2:00pm20 mins
Track 1: Cell Line Development & Engineering
KEYNOTE: Direct Comparison Between CHO & Plant Cell Line: Practicality & Quality
- Somen Nandi - Adjunct Professor, University of California, Davis
1:40pm - 2:00pm20 mins
Track 2: Cell Culture
Qualification of Scale Up and Scale Down Models for Clinical and Commercial Manufacturing
- Gurpreet Tahim - Research Associate, Seagen
1:40pm - 2:00pm20 mins
Track 3: Recovery & Purification
Lab Automation Enhancements for Faster Downstream Process Development
- Juan Cueva - Associate Scientist III, Process Biochemistry, Biogen
1:40pm - 2:00pm20 mins
Track 4: Manufacturing Strategy & Bioprocessing 4.0
Applying data-driven models in biopharmaceutical manufacturing to improve real-time decision-making
- Chris Garvin - Director, Digital Manufacturing, Amgen
1:40pm - 2:00pm20 mins
Track 5: Intensified & Continuous Processing
Process Intensification: Implementation of Continuous Manufacturing in Upstream Processing
- William Napoli - Scientist, Sanofi
1:40pm - 2:00pm20 mins
Track 6: Cell & Gene Therapies
CMC Platform Development and Late Stage Considerations for AAV Gene Therapy Products
- James Warren - VP Pharmceutical Development, Ultragenyx
2:05pm - 2:35pm30 mins
Track 1: Cell Line Development & Engineering
PANEL: Utilizing an Assortment of Cell Line Types for Complex Biopharmaceutical Production
- Chris Love - Professor of Chemical Engineering, MIT
- Susan Sharfstein, PhD - Professor of Nanobioscience, SUNY Polytechnic Institute
2:05pm - 2:35pm30 mins
Track 2: Cell Culture
From Early Research to Pre-Clinical Molecules: Development of a CHO based transient / stable pool platform addressing the needs of the deliverable
- Saurabh Sen - Associate Director, Cell Line Development, Sanofi
2:05pm - 2:35pm30 mins
Track 3: Recovery & Purification
Panel Discussion - Live
2:05pm - 2:35pm30 mins
Track 4: Manufacturing Strategy & Bioprocessing 4.0
PANEL: Steps Toward Digital Transformation – Overcoming Setup, Data Management, Integration Solution and Security Challenges
2:05pm - 2:35pm30 mins
Track 5: Intensified & Continuous Processing
Panel Discussion - Live
2:05pm - 2:25pm20 mins
Track 6: Cell & Gene Therapies
Comprehensive Characterization of Viral Vector Particles via CE/UV and LC/MS
- Christopher Colangelo, Ph.D., MBA - Biopharma Business Development Leader, Agilent Technologies, Inc.
2:35pm - 3:00pm25 mins
Networking Time – Schedule Meetings, Visit Exhibit Booths & Poster Rooms
3:00pm - 4:00pm60 mins
Diversity, Equity and Inclusion Discussion - Expand Your Market Success, Build Talent Pipelines, Foster Existing Staff Growth
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams
Formats